The survival curve demonstrated that patients with high ZIP11 RNA expression within their cervical cancer tumors had a 63% chance of surviving over 5 years, while those with low ZIP11 RNA had a 72% survival rate (Figure 1G and Supplementary Table S3). Here, SLC39A11 is linked to cervical cancer.